|
|
.
See Category: Diseases of the musculoskeletal system and connective tissue
See Header: Pathological fracture in neoplastic disease, right humerus
ICD-10 (CM) Code and Descriptor
|
M84.521K |
Pathological fracture in neoplastic disease, right humerus, subsequent encounter for fracture with nonunion
|
M84521K utilizaton on OPPS claims.*
Primary
ICD10 Code |
ICD10
Position 2 |
ICD10
Position 3 |
ICD10
Position 4 |
ICD10
Position 5 |
ICD10
Position 6 |
ICD10
Position 7 |
ICD10
Position 17 |
ICD10
Position 19 |
| 51.67%
|
13.33%
|
6.67%
|
5.00%
|
1.67%
|
3.33%
|
1.67%
|
1.67%
|
15.00%
|
* Medicare Part A utilization data is derived from the 100% 2023 Outpatient (Fee-for-Service) Standard Analytical File.
Commonly Associated Procedure Codes for M84.521K*:
| CPT |
Description |
Number of Claims |
Sum Performed |
|
82962
|
GLUCOSE BLOOD TEST |
22
|
51
|
|
A9270
|
NON-COVERED ITEM OR SERVICE |
20
|
99
|
|
J7500
|
AZATHIOPRINE ORAL 50MG |
14
|
30
|
|
97110
|
THERAPEUTIC EXERCISES |
12
|
12
|
|
97530
|
THERAPEUTIC ACTIVITIES |
12
|
14
|
|
G0463
|
HOSPITAL OUTPT CLINIC VISIT |
10
|
10
|
|
80048
|
METABOLIC PANEL TOTAL CA |
9
|
9
|
|
J0690
|
CEFAZOLIN SODIUM INJECTION |
8
|
36
|
|
J3490
|
DRUGS UNCLASSIFIED INJECTION |
8
|
46
|
|
85027
|
COMPLETE CBC AUTOMATED |
7
|
7
|
|
94760
|
MEASURE BLOOD OXYGEN LEVEL |
6
|
6
|
|
97535
|
SELF CARE MNGMENT TRAINING |
6
|
8
|
|
J3010
|
FENTANYL CITRATE INJECTION |
5
|
10
|
|
97116
|
GAIT TRAINING THERAPY |
5
|
5
|
|
73060
|
X-RAY EXAM OF HUMERUS |
4
|
4
|
|
J2405
|
ONDANSETRON HCL INJECTION |
4
|
16
|
|
73030
|
X-RAY EXAM OF SHOULDER |
4
|
4
|
|
J1100
|
DEXAMETHASONE SODIUM PHOS |
3
|
40
|
|
C1713
|
ANCHOR/SCREW BN/BN,TIS/BN |
3
|
11
|
|
85025
|
COMPLETE CBC W/AUTO DIFF WBC |
3
|
3
|
* Derived from 100% 2021 Outpatient (Fee-for-Service) Standard Analytical File.
M84.521K related to the following DRG Codes:
564-566
|
